Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG 2025-12-17 14:47
Robotware.ai Advances AI Poultry Disease Detection PoC in Malaysia with SDEC 2025-12-17 09:00
Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma 2025-12-17 09:00
Jiaying Pharmaceutical: A New Pathway for the Industrialization of Century-Old Hakka Medicine 2025-12-17 08:00
Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development 2025-12-16 08:30
MEDEZE Receives Frost & Sullivan's 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine 2025-12-15 17:00
Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor 2025-12-15 17:00
Global Spotlight｜POGMENT Biomimetic Collagen "Stable Triple Helix" Breakthrough Stuns the World--Extraordinary and Breathtaking 2025-12-15 16:32
DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT 2025-12-15 15:02
Everest Medicines Announces 2030 Strategy and Increase in Shareholdings by Directors and Substantial Shareholder 2025-12-15 12:40
Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial 2025-12-15 08:25
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO 2025-12-11 14:12
Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006 2025-12-10 22:05
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics 2025-12-10 21:00
Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment 2025-12-10 17:15
Stay True to Our Original Aspiration, Forge Ahead into the Future｜Alphamab Oncology 2025 R&D Day Successfully Held 2025-12-10 14:20
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs 2025-12-10 09:30
Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights 2025-12-10 08:00
Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement Market 2025-12-09 10:30
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide 2025-12-09 03:11
1 2 3 4 5 264